tiprankstipranks
Rapid Dose Therapeutics Innovates Vaccine Delivery
Company Announcements

Rapid Dose Therapeutics Innovates Vaccine Delivery

Rapid Dose Therapeutics Corp (TSE:DOSE) has released an update.

Don't Miss Our Christmas Offers:

Rapid Dose Therapeutics Corp has secured an additional Mitacs Accelerate grant to advance their QuickStrip™ Oral Thin Film technology for vaccine delivery, eliminating the need for intramuscular injections and cold-chain storage. The ongoing research partnership with McMaster University, supported by a total of $85,000 in grants, is set to revolutionize vaccination methods by enabling buccal or sublingual administration. CEO Mark Upsdell highlights the potential for QuickStrip™ to address healthcare delivery and environmental challenges, particularly in regions where traditional vaccine logistics are problematic.

For further insights into TSE:DOSE stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskRapid Dose Therapeutics Unveils Lidocaine Oral Strip Innovation
TipRanks Canadian Auto-Generated NewsdeskRapid Dose Therapeutics Issues Shares for Debt Interest
TipRanks Canadian Auto-Generated NewsdeskRapid Dose Therapeutics Extends Financing Window
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App